MRK Stock - Merck & Co Inc.

MRK Stock Chart

MRK Profile

Merck & Co., Inc. operates globally as a healthcare company, divided into two main segments: Pharmaceutical and Animal Health. The Pharmaceutical segment focuses on a wide range of human health products, including oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes treatments. Additionally, it offers vaccine products for pediatric, adolescent, and adult preventive care.

In the Animal Health segment, Merck develops, manufacttures, and markets veterinary pharmaceuticals, vaccines, and health management solutions. This segment also provides digitally connected products for identification, traceability, and monitoring of animals. Its customer base includes drug wholesalers, retailers, hospitals, government agencies, managed healthcare providers, physicians, veterinarians, and animal producers.

Founded in 1891 and headquartered in Kenilworth, New Jersey, Merck & Co., Inc. has established strategic collaborations with industry leaders such as AstraZeneca PLC, Bayer AG, Eisai Co., Ltd., Ridgeback Biotherapeutics, and Gilead Sciences, Inc. These partnerships are focused on developing and commercializing long-acting treatments for HIV and other therapeutic areas. Merck remains committed to advancing healthcare through innovation and collaboration across its diverse product portfolio.

MRK Revenue Chart

MRK Earnings

Analyst Ratings